The apelin/APJ system also plays significant roles in pathological conditions, acting as a potential gastric injury protectant, a marker for gastric and colon cancer, a lipid regulator for nonalcoholic fatty liver disease (NAFLD) and a mediator of fibrosis. The gene discussed is APLN; the disease is metabolic dysfunction-associated steatotic liver disease.